20.05 2021

Katren Holding Publishes Marketing Annual Report for 2020

Katren JSC has published its annual marketing report on the results of the holding’s activities in 2020 on its website, www.katrengroup.ru

The document presents the key business directions and the main results for each company in Katren JSC.

In his address Vladimir Spiridonov, General Director of Katren JSC, pointed out that two factors have had a significant impact on the development of the pharmacy sector over the last year: the system of product marking that was introduced on June 1, 2020, and the COVID 19 pandemic. The company has successfully adapted to the new working conditions.

In 2021, Katren JSC plans to continue with the optimization of its business processes and the development of on-line sales. This is the most appropriate course of action in view of the ongoing restrictions related to the pandemic.

In 2020, the Group’s turnover was 269 billion roubles, and the net profit for the company’s shareholders was 4.8 billion roubles. The Group’s 2020 reports were audited by the independent auditing company Deloitte.

The main company in the Holding, SPC Katren JSC, operates as a distributor of medicines in all federal districts and constituent entities of the Russian Federation. In 2020, SPC Katren JSC reported gross revenue of 212.2 billion rubles, and a net profit of 4.8 billion rubles. 

In the retail segment, the Melodiya Zdorovya chain of pharmacies in 2020 retained its position among the top 10 pharmacy chains in terms of their share of the commercial retail market, and its leading position terms of trade turnover per shop (according to data from RNC Pharma). Its trade turnover increased by 27% in 2020. As of the end of 2020, the pharmacy chain had 839 pharmacies in 46 constituent entities of the Russian Federation.

 Katren JSC’s annual marketing report for 2020 can be found in the “About the Group/ Annual Marketing Report” section on the Holding’s website.

The Annual Marketing Report does not constitute an annual report for the purposes of Chapter 70 of Regulations No. 454-P of the Russian Central Bank On the Disclosure of Information by Issuers of Securities, dated December 30, 2014. The text of the annual report prepared in accordance with the above requirements will be published on this page once it has been approved by the General Meeting of Shareholders. 

Information about the Company

Katren JSC is the holding company of the Group, and operates in the distribution and retail sectors of pharmaceutical markets. Katren JSC’s main business is concentrated in the Russian Federation.